Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
Recruiting now · Not applicable
Conditions studied: Chronic Obstructive Lung Disease, Chronic Obstructive Pulmonary Disease
In brief
To evaluate the regenerative capacities of mesenchymal cells composing the microenvironment of alveolar type 2 cells in a population of patients, undergoing thoracic surgery for suspected cancer, who are smokers with and without COPD compared to non-smokers patients
Key facts
- Study ID
- NCT05227547
- Run by
- Centre Hospitalier Intercommunal Creteil
- People needed
- 186
- Starts
- 2022-10-05
- Expected to finish
- 2030-10-05
- Last updated by the study team
- 2025-09-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18
- Patient undergoing lung resection surgery (lobectomy, pneumonectomy, segmentectomy) for cancer or suspected cancer
- Acceptance to participate in the protocol
- Affiliated to a social security plan
You may not qualify if…
- Chronic autoimmune disease
- Patient under guardianship or curators
- Neo-adjuvant chemotherapy
- History of thoracic radiotherapy
- Pregnant woman
- Minor patient
- Person not able to consent
- Person deprived of liberty
Where it is running
- Rousseau-Bussac — Créteil, France (enrolling)
- Hopital Cochin — Paris, France
- HEGP — Paris, France
- Hopital Tenon — Paris, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.